DRG1 Antibodies

Santa Cruz Biotechnology offers a broad range of DRG1 monoclonal antibodies for research focused on understanding DRG1 protein functions. DRG1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DRG1 protein plays essential roles in cellular stress responses and influences cell growth and differentiation processes. Research has shown DRG1 expression patterns vary significantly across physiological and pathological conditions, highlighting its importance in cancer and neurodegenerative disease studies. Investigating DRG1 functions continues to reveal potential therapeutic targets and biomarkers for monitoring disease progression. Current research demonstrates DRG1's involvement in multiple cellular pathways and regulatory mechanisms. Understanding DRG1's molecular interactions provides valuable insights into cellular homeostasis and stress response mechanisms. Ongoing studies of DRG1 contribute to developing new therapeutic approaches for various diseases. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of DRG1's role in health and disease.